dc.contributor.author | Nita Ernawati | |
dc.date.accessioned | 2013-12-17T02:25:27Z | |
dc.date.available | 2013-12-17T02:25:27Z | |
dc.date.issued | 2013-12-17 | |
dc.identifier.nim | NIM092210101097 | |
dc.identifier.uri | http://repository.unej.ac.id/handle/123456789/9323 | |
dc.description.abstract | ABSTRACT
5-fluorouracil is an antimetabolite class of anticancer agents that work induces
apoptosis by inhibiting thymidilic acid biosynthesis. A novel 5-fluorouracil
derivatives, 1-(4-trifluoromethylbenzoyloxymethyl)-5-fluorouracil were synthesized
by two steps reaction. The first step is alkylation reaction between 5-fluorouracil,
formaldehyde and aquadest to produce 1-hidroxymethyl-5-fluorouracil. The second
step is benzoylation reaction between 1-hidroxymethyl-5-fluorouracil and 4trifluoromethylbenzoylchloride
for
11
hours
to
produce
the target compound. Target
compound purified by column chromatography. Purified compound characterized
and identified by
1
HNMR and FTIR KBr. Product compound form white needles
crystal with melting range 172-174
o
C. Spectra of
1
HNMR and FTIR KBr showed that
pure 1-(4-trifluoromethylbenzoyloxymethyl)-5-fluorouracil was successfully
synthesized. | en_US |
dc.language.iso | other | en_US |
dc.relation.ispartofseries | 092210101097; | |
dc.subject | 5-fluorouracil 1-4-trifluoromethylbenzoyloxymethyl-5-fluorouracil alkylation anticancer benzoylation | en_US |
dc.title | SINTESIS 1-(4-TRIFLUOROMETILBENZOILOKSIMETIL)-5FLUOROURASIL SEBAGAI UPAYA PENGEMBANGAN OBAT ANTIKANKER | en_US |
dc.type | Other | en_US |